Debt-to-equity of Greenwich LifeSciences, Inc. from 30 Jun 2021 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Greenwich LifeSciences, Inc. quarterly Debt-to-equity in % history and change rate from 30 Jun 2021 to 30 Sep 2025.
  • Greenwich LifeSciences, Inc. Debt-to-equity for the quarter ending 30 Sep 2025 was 84%, a 565% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

Greenwich LifeSciences, Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 84% +72% +565% 30 Sep 2025
Q2 2025 54% +45% +512% 30 Jun 2025
Q1 2025 35% +31% +762% 31 Mar 2025
Q4 2024 22% +19% +651% 31 Dec 2024
Q3 2024 13% +10% +414% 30 Sep 2024
Q2 2024 8.8% +6.8% +332% 30 Jun 2024
Q1 2024 4.1% +2.4% +143% 31 Mar 2024
Q4 2023 3% +1.5% +100% 31 Dec 2023
Q3 2023 2.5% +1.1% +78% 30 Sep 2023
Q2 2023 2% +0.61% +43% 30 Jun 2023
Q1 2023 1.7% +0.02% +1.2% 31 Mar 2023
Q4 2022 1.5% -0.41% -22% 31 Dec 2022
Q3 2022 1.4% -1.1% -44% 30 Sep 2022
Q2 2022 1.4% -2.9% -67% 30 Jun 2022
Q1 2022 1.7% 31 Mar 2022
Q4 2021 1.9% 31 Dec 2021
Q3 2021 2.5% 30 Sep 2021
Q2 2021 4.4% 30 Jun 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.